Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?
Alsyouf M, Ladi-Seyedian SS, Konety B, Pohar K, Holzbeierlein JM, Kates M, Willard B, Taylor JM, Liao JC, Kaimakliotis HZ, Porten SP, Steinberg GD, Tyson MD, Lotan Y, Daneshmand S; Blue Light Cystoscopy with Cysview Registry Group. Alsyouf M, et al. Among authors: konety b. Urol Oncol. 2023 Feb;41(2):109.e9-109.e14. doi: 10.1016/j.urolonc.2022.10.026. Epub 2022 Nov 24. Urol Oncol. 2023. PMID: 36435710
Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification.
Lotan Y, Raman JD, Konety B, Daneshmand S, Schroeck F, Shariat SF, Black P, de Lange M, Asroff S, Goldfischer E, Efros M, Chong KT, Huang E, Chua HL, Wu QH, Yeow S, Lau W, Yong J, Eng M. Lotan Y, et al. Among authors: konety b. J Urol. 2023 Apr;209(4):762-772. doi: 10.1097/JU.0000000000003126. Epub 2022 Dec 30. J Urol. 2023. PMID: 36583640
Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy: Insights from a Multicenter Registry.
Ladi-Seyedian SS, Ghoreifi A, Konety B, Pohar K, Holzbeierlein JM, Taylor J, Kates M, Willard B, Taylor JM, Liao JC, Kaimakliotis HZ, Porten SP, Steinberg GD, Tyson MD, Lotan Y, Daneshmand S, Blue Light Cystoscopy With Cysview Registry Group. Ladi-Seyedian SS, et al. Among authors: konety b. Cancers (Basel). 2024 Mar 24;16(7):1268. doi: 10.3390/cancers16071268. Cancers (Basel). 2024. PMID: 38610946 Free PMC article.
Commentary on Novitas LCD.
Lotan Y, Barocas DA, Chang SS, Daneshmand S, Konety B, Meeks JJ, Porten S, Raman JD, Rosser CJ, Scarpato KR, Sexton WJ, Sfakianos JP, Shore ND, Svatek RS. Lotan Y, et al. Among authors: konety b. Bladder Cancer. 2023 Dec 13;9(4):305-312. doi: 10.3233/BLC-230057. eCollection 2023. Bladder Cancer. 2023. PMID: 38994243 Free PMC article. No abstract available.
A multi-institutional study of 1,111 men with 4K score, multiparametric magnetic resonance imaging, and prostate biopsy.
Thomas J, Atluri S, Zucker I, Reis I, Kwon D, Kim E, Tewari A, Patel V, Wagaskar V, Konety B, Kasraeian A, Czarniecki S, Thoreson G, Soodana-Prakash N, Ritch C, Nahar B, Gonzalgo M, Kava B, Parekh D, Punnen S. Thomas J, et al. Among authors: konety b. Urol Oncol. 2023 Oct;41(10):430.e9-430.e16. doi: 10.1016/j.urolonc.2023.07.001. Epub 2023 Aug 4. Urol Oncol. 2023. PMID: 37544833
Identifying the best candidate for focal therapy: a comprehensive review.
Ghoreifi A, Gomella L, Hu JC, Konety B, Lunelli L, Rastinehad AR, Salomon G, Taneja S, Tourinho-Barbosa R, Lebastchi AH. Ghoreifi A, et al. Among authors: konety b. Prostate Cancer Prostatic Dis. 2024 Oct 23. doi: 10.1038/s41391-024-00907-y. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 39443815 Review.
Comparison of Robotic vs Open Cystectomy: A Systematic Review.
Sathianathen NJ, Pan HYC, Furrer M, Thomas B, Dundee P, Corcoran N, Weight CJ, Konety B, Nair R, Lawrentschuk N. Sathianathen NJ, et al. Among authors: konety b. Bladder Cancer. 2023 Sep 25;9(3):253-269. doi: 10.3233/BLC-220065. eCollection 2023. Bladder Cancer. 2023. PMID: 38993188 Free PMC article.
393 results